Literature DB >> 2884130

The effect of the natural protein inhibitor on H+-ATPase hepatoma 22a mitochondria.

B V Chernyak, V F Dukhovich.   

Abstract

The uncoupler-induced inactivation of H+-ATPase in hepatoma 22a and mouse liver mitochondria has been studied. The dependence of this process on delta microH, and pH and ATP was established. The inactivated ATPase could be reactivated at alkaline pH values in the absence of ATP. These data indicate that the inactivation is apparently caused by the natural protein inhibitor. ATP- and pH-dependent decrease of ATPase activity is also observed after Lubrol-WX disruption of mitochondria. It can be proposed that practically all ATPase molecules in hepatoma mitochondria are in a catalytically active complex with the protein inhibitor. At low delta microH this complex is inactivated via reversible pH-dependent and irreversible ATP-dependent rearrangements. The pH-dependent rearrangement of the isolated protein inhibitor from hepatoma mitochondria is also observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884130     DOI: 10.1016/0014-5793(87)80166-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Regulation of the mitochondrial ATPase in situ in cardiac muscle: role of the inhibitor subunit.

Authors:  W Rouslin
Journal:  J Bioenerg Biomembr       Date:  1991-12       Impact factor: 2.945

Review 2.  Control of mitochondrial ATP synthesis in the heart.

Authors:  D A Harris; A M Das
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

3.  IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation.

Authors:  L Shen; L Zhi; W Hu; M X Wu
Journal:  Cell Death Differ       Date:  2008-12-19       Impact factor: 15.828

4.  Effects of Zn2+ on the activity and binding of the mitochondrial ATPase inhibitor protein, IF1.

Authors:  W Rouslin; C W Broge; B V Chernyak
Journal:  J Bioenerg Biomembr       Date:  1993-06       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.